<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:department>Blizard Institute of Cell and Molecular</gtr:department><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/93F6CFE6-C90D-4EA2-944B-65C3C11014AF"><gtr:id>93F6CFE6-C90D-4EA2-944B-65C3C11014AF</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Alexander</gtr:otherNames><gtr:surname>van Heel</gtr:surname><gtr:orcidId>0000-0002-0637-2265</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1001158"><gtr:id>389198C0-1889-4D9D-A6C6-38CADE095441</gtr:id><gtr:title>Exome sequencing and mutation identification in familial coeliac disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1001158</gtr:grantReference><gtr:abstractText>Coeliac disease (a common immune condition of the gut caused by reaction to dietary wheat and cereals) runs strongly in families, however at most half of this heritability can be explained by our current knowledge of inherited genetic risk factors.
We think that mutations in DNA sequence that alters the protein coding sequence of genes may contribute to coeliac disease heritability. There is evidence for this in other diseases. These risk mutations are likely to be relatively rare in the population.
 We propose to use new technology to sequence all protein coding genes (the exome) in 50 selected very large multiply affected families with coeliac disease. Each family has at least 5 people with coeliac disease, one has 13 affected individuals. We will study three distantly related individuals per family and look for mutations shared between the people with coeliac disease. This will enable us to narrow down the possibilities from the many thousands of variants the sequencing uncovers.
We will also use relatively cheap BeadChips to analyse hundreds of thousands of known variants in every affected individuals in each family. This will give us complementary information, showing which large regions of the genome are shared between the affected individuals.
We will subsequently test all individuals (affected and unaffected) in a family for promising candidates for disease causing risk mutations.
Once we have found new disease risk mutations in several genes, we will then look for different, possibly rare mutations in thousands of more samples. Finding multiple mutations in a gene gives further evidence that we are on the right track, and also provides information to develop diagnostic and risk-predicting tests. 
 Finally, we will also test several thousand mutations in over ten thousand coeliac and healthy individuals. This will give further evidence to implicate disease mutations, and tell us precise details about each mutation.
 Identifying rare high effect size mutations in coeliac disease will give us direct leads into how disease develops and possibly identify new targets for treatments. We have previously shown that insights in coeliac disease are likely to give insights relevant to other chronic immune diseases.These rare mutations often have readily predictable consequences, and are of high value for disease understanding. Follow on studies will investigate the effects of these mutations on biological function. The study will likely also generate methodological advances relevant to other conditions.</gtr:abstractText><gtr:technicalSummary>Coeliac disease is highly heritable, however at most 50% of this heritability is explained by HLA-DQ and new risk variants from genome wide association studies.
We hypothesise that rare heritable genetic mutations (protein coding changes) of relatively large effect size (allelic odds ratios ~ 2 - 5) account for a substantial proportion of the remaining heritability in coeliac disease.
 We propose to use whole exome resequencing to identify mutations in 50 selected very large multiply affected families. We will resequence exons of all protein coding genes in, where possible, three distantly related individuals per family (each pair at least 1st cousin or more distant). We have already identified and collected DNA and phenotypes on over 100 families with at least 5 affected coeliac individuals and will select 50 of the most informative families to exome resequence 3 distantly related affecteds per family..
Importantly, the use of relatively inexpensive genome wide SNP chips in large pedigrees allows us to accurately identify extended genomic segments shared between distantly related affecteds that are likely to be the regions containing mutations. We will subsequently genotype a set of candidate mutations per family in all affected and unaffected individuals to confirm segregation with affection status. 
 We will then perform deep resequencing of the 4 most interesting genes containing mutations segregating with disease in ~1000 samples, to obtain the full mutation spectrum in coeliac disease. We will proceed to genotype these mutations; promising mutations from exome resequencing in sporadic extreme-phenotype coeliac disease (a separate Coeliac UK funded project); and other promising mutations from familial resequencing in our entire collection of over 8000 cases and 8000 controls.
 Identifying rare high effect size mutations in coeliac disease will give us direct leads into the causation of disease, and identify novel therapeutic targets. Rare mutations often have readily predicatable pathological consequences, e.g. stop mutations or deleted exons. Follow on studies will investigate the effects of these mutations on biological function. The study will likely also generate methodological advances relevant to other diseases with complex inheritance.</gtr:technicalSummary><gtr:fund><gtr:end>2014-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1161369</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Biosciences</gtr:department><gtr:description>Dr Vincent Plagnol: statistics and informatics</gtr:description><gtr:id>5E2AC80E-2702-4D04-A66B-94D67E3742BB</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>UbQyZGmmUVb-1</gtr:outcomeId><gtr:partnerContribution>Data analysis</gtr:partnerContribution><gtr:piContribution>Analysis of high throughput sequencing data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Coeliac UK</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>D0378470-CF80-479B-BF1C-59A0E23D6670</gtr:id><gtr:impact>Research meeting of patient charity Coeliac UK - mixed audience including patients, other lay individuals with an interest, charity members, health related professionals, clinicians.

none</gtr:impact><gtr:outcomeId>Y9EJ7StyWYn</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Research Capabilities and Technologies Initiative, Phenotyping and Experimental Medicine Centre for naturally occurring Gene Knock- Outs in Humans</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M009017/1</gtr:fundingRef><gtr:id>78483910-02EE-4C32-B03E-4B28BC655A98</gtr:id><gtr:outcomeId>56d6c0a02304f5.54409603</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Strategic Award</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>102627</gtr:fundingRef><gtr:id>CC77E5C4-872C-4F6E-BAF6-B1E3CCAA16F5</gtr:id><gtr:outcomeId>544e8db5a94370.81840001</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>58700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Comprehensive Biomedical Research Centre, Guy's and St Thomas</gtr:department><gtr:description>NIHR Biomedical Research Centre (coapplicant, Kings College London)</gtr:description><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>7D99F7AA-3270-4BFA-A11E-6EFDA944178B</gtr:id><gtr:outcomeId>GsAt4z2e1Tc0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>91B96FD9-BC24-40B4-8D14-22F65C56FD5D</gtr:id><gtr:title>Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04b42c4821e619d19b00d278b28593a7"><gtr:id>04b42c4821e619d19b00d278b28593a7</gtr:id><gtr:otherNames>Romanos J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>544e8cdcaf1e13.91882109</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0AB589F-AB1D-42E9-8096-3AB1E8F4F2ED</gtr:id><gtr:title>Genetic insights into common pathways and complex relationships among immune-mediated diseases.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48a8c35be7425a6d8f79136f19f9d89d"><gtr:id>48a8c35be7425a6d8f79136f19f9d89d</gtr:id><gtr:otherNames>Parkes M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-0056</gtr:issn><gtr:outcomeId>pm_12522_22_23917628</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43C58486-9FAE-4859-AF5D-C3B2AD8EEB56</gtr:id><gtr:title>A genome-wide assessment of the role of untagged copy number variants in type 1 diabetes.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb437bded397ab10812e2981bc06cfb1"><gtr:id>fb437bded397ab10812e2981bc06cfb1</gtr:id><gtr:otherNames>Zanda M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_540e175e1757ef805</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B151CF5-AD9D-4417-83A5-95ABAC293918</gtr:id><gtr:title>Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5a699108cccc63f5bf4495f272d4bd3"><gtr:id>c5a699108cccc63f5bf4495f272d4bd3</gtr:id><gtr:otherNames>Prins BP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>58adcfebd847f1.13386298</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3132E6E-FA28-47DA-9EDE-CE3479E6EA5B</gtr:id><gtr:title>Mutations in AQP5, encoding a water-channel protein, cause autosomal-dominant diffuse nonepidermolytic palmoplantar keratoderma.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6cb0132e63f15da395f14e2f5217726"><gtr:id>a6cb0132e63f15da395f14e2f5217726</gtr:id><gtr:otherNames>Blaydon DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_540e175e1755e7268</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8224DE6-CB3B-41C9-8398-4C55AC8C19AC</gtr:id><gtr:title>Validity of the family-based association test for copy number variant data in the case of non-linear intensity-genotype relationship.</gtr:title><gtr:parentPublicationTitle>Genetic epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb437bded397ab10812e2981bc06cfb1"><gtr:id>fb437bded397ab10812e2981bc06cfb1</gtr:id><gtr:otherNames>Zanda M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0741-0395</gtr:issn><gtr:outcomeId>585d5a9091b080.06270677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF6F7DB9-2013-464D-8B63-900465433E69</gtr:id><gtr:title>Negligible impact of rare autoimmune-locus coding-region variants on missing heritability.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28d5e44cfd0fb461260062e89bab9868"><gtr:id>28d5e44cfd0fb461260062e89bab9868</gtr:id><gtr:otherNames>Hunt KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_12522_22_23698362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5024620D-3FF0-468D-8631-23ACCC840C70</gtr:id><gtr:title>LRBA gene deletion in a patient presenting with autoimmunity without hypogammaglobulinemia.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab68f830244344612e7221a866f3a2b5"><gtr:id>ab68f830244344612e7221a866f3a2b5</gtr:id><gtr:otherNames>Burns SO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>pm_12522_22_22981790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F80B8312-D190-4E7E-8BB6-CB5E82CFA7F4</gtr:id><gtr:title>Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e32a4b9f9495ad715f10996e8155ce9f"><gtr:id>e32a4b9f9495ad715f10996e8155ce9f</gtr:id><gtr:otherNames>Trynka G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_12522_22_22057235</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2495B2CB-63E4-4F81-A6BF-90D672FD6C67</gtr:id><gtr:title>A robust model for read count data in exome sequencing experiments and implications for copy number variant calling.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5573c04333fe2be013ba5a135e3dabd6"><gtr:id>5573c04333fe2be013ba5a135e3dabd6</gtr:id><gtr:otherNames>Plagnol V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn><gtr:outcomeId>pm_12522_22_22942019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA0AD8ED-7DC2-447B-B45B-A44E725100FF</gtr:id><gtr:title>Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2747fca180e0fb9a8015477c84355107"><gtr:id>2747fca180e0fb9a8015477c84355107</gtr:id><gtr:otherNames>Fu J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_12522_22_22275870</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6038B35A-FAE5-4419-A4EF-16ED888345A5</gtr:id><gtr:title>CNV analysis in Tourette syndrome implicates large genomic rearrangements in COL8A1 and NRXN1.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30af02d0ea55aad1528bd0d1f54d0f4c"><gtr:id>30af02d0ea55aad1528bd0d1f54d0f4c</gtr:id><gtr:otherNames>Nag A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12522_22_23533600</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E85C2DD-7966-46D0-A861-32272CDC8110</gtr:id><gtr:title>Use of targeted exome sequencing as a diagnostic tool for Familial Hypercholesterolaemia.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58813bb596fc9ef689b1335d41164030"><gtr:id>58813bb596fc9ef689b1335d41164030</gtr:id><gtr:otherNames>Futema M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>doi_55f9859857bf4140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71C7EAF1-9750-4FAD-8FAC-C884E3DEF37B</gtr:id><gtr:title>Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58813bb596fc9ef689b1335d41164030"><gtr:id>58813bb596fc9ef689b1335d41164030</gtr:id><gtr:otherNames>Futema M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>pm_540e175e17589fc67</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD6C7AB4-85B7-4FD3-BA6F-EF0BA4B55866</gtr:id><gtr:title>Mutations in ARL2BP, encoding ADP-ribosylation-factor-like 2 binding protein, cause autosomal-recessive retinitis pigmentosa.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/361aafcc5b38ec391e9b03d6ea6d7f4a"><gtr:id>361aafcc5b38ec391e9b03d6ea6d7f4a</gtr:id><gtr:otherNames>Davidson AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_540e175e175692d42</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E364CE1-BE44-4433-8065-C02C3E9C1CB1</gtr:id><gtr:title>Bayesian test for colocalisation between pairs of genetic association studies using summary statistics.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/308aadbabce495c9eea65eeb6a1cc104"><gtr:id>308aadbabce495c9eea65eeb6a1cc104</gtr:id><gtr:otherNames>Giambartolomei C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_540e175e1757449fc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B8AF4CB-5E79-462D-9283-30E739BEC567</gtr:id><gtr:title>Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c6f9453547ced7dcd1eeaf2768a8c53"><gtr:id>2c6f9453547ced7dcd1eeaf2768a8c53</gtr:id><gtr:otherNames>Lenz TL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58adcfebad5c60.16290137</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D38F0D2F-5FF9-4D45-9095-3064A3867A4A</gtr:id><gtr:title>Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3965fe730b33bfa3e5aa578fea4398db"><gtr:id>3965fe730b33bfa3e5aa578fea4398db</gtr:id><gtr:otherNames>Lopes LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>pm_12522_22_23396983</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48730A71-E597-4815-B0DD-A2C3897EA50E</gtr:id><gtr:title>Mutations in CSTA, encoding Cystatin A, underlie exfoliative ichthyosis and reveal a role for this protease inhibitor in cell-cell adhesion.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6cb0132e63f15da395f14e2f5217726"><gtr:id>a6cb0132e63f15da395f14e2f5217726</gtr:id><gtr:otherNames>Blaydon DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_12522_22_21944047</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0676D61-A5CE-45D5-936E-22E73B985DDB</gtr:id><gtr:title>Inflammatory skin and bowel disease linked to ADAM17 deletion.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6cb0132e63f15da395f14e2f5217726"><gtr:id>a6cb0132e63f15da395f14e2f5217726</gtr:id><gtr:otherNames>Blaydon DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>pm_12522_22_22010916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A04C661C-30D3-4AF8-B48A-7AEB0045A366</gtr:id><gtr:title>RP1L1 variants are associated with a spectrum of inherited retinal diseases including retinitis pigmentosa and occult macular dystrophy.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/361aafcc5b38ec391e9b03d6ea6d7f4a"><gtr:id>361aafcc5b38ec391e9b03d6ea6d7f4a</gtr:id><gtr:otherNames>Davidson AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>pm_12522_22_23281133</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BE3C213-EFC6-4F7C-B476-B8B71EEED3A5</gtr:id><gtr:title>Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28d5e44cfd0fb461260062e89bab9868"><gtr:id>28d5e44cfd0fb461260062e89bab9868</gtr:id><gtr:otherNames>Hunt KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_12522_22_22200769</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>946F5252-1993-44DC-B533-352D4120B730</gtr:id><gtr:title>Exome sequencing of 75 individuals from multiply affected coeliac families and large scale resequencing follow up.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e26c327ad00a077602f4661e22c64d6c"><gtr:id>e26c327ad00a077602f4661e22c64d6c</gtr:id><gtr:otherNames>Mistry V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5675df30e6562</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1001158</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>